相关实验视频

Updated: Jul 19, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

作为ER阳性乳腺癌的预后标志物,AGR2和FOXA1

Meng Zhou¹, Xing-Li Gan¹, Yue-Xiang Ren²

¹School of Public Health, Sun Yat-Sen University, 74 Zhongshan 2Nd Rd, Guangzhou, 510080, China.

|August 11, 2023

概括

叉盒A1 (FOXA1) 和前梯度2 (AGR2) 的组合显著影响乳腺癌预后,特别是在ER阳性病例中. 低水平的FOXA1和AGR2都表明患者的预后更好.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物标志物研究生物标志物研究

背景情况:

在乳腺癌中,分叉盒A1 (FOXA1) 和前梯度2 (AGR2) 的个体预后意义已确定.
建议FOXA1和AGR2之间的相互作用,根据雌激素受体 (ER) 状态而有所不同.

研究的目的:

研究AGR2和FOXA1在乳腺癌预后中的统计相互作用.
为了评估AGR2和FOXA1的综合预后作用,按ER状态分层.

主要方法:

免疫组织化学用于评估915名乳腺癌患者瘤组织中的AGR2和FOXA1表达.
使用生存率和Cox比例危险分析来确定预后关系和统计相互作用.

主要成果:

在ER阳性乳腺癌患者的无进展生存期 (PFS) 中,观察到AGR2和FOXA1之间的显著统计相互作用.
在ER阳性病例中,高FOXA1预测的预后只有低AGR2,反之亦然.
与其他组相比,具有低水平AGR2和FOXA1的患者表现出明显更长的PFS.

结论:

关于ER阳性乳腺癌的预后,AGR2和FOXA1之间存在显著的统计相互作用.
对AGR2和FOXA1的综合评估可以作为ER阳性乳腺癌患者更有效的预后标志物.

关键词:

在 AGR2 中,AGR2 是乳腺癌是什么? 乳腺癌是什么我们的FOXA1A1 预测预后预测预测

更多相关视频

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...